Nicolai Tangen - AKO Capital LLP
Holding/activity history for Thermo Fisher Scientific (TMO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.14 | SEC | ||
| 2025 Q2 | 26,427 | 0.14 | Reduce 92.06% | 1.98 | $405.46 | $10,715,000 | SEC |
| 2025 Q1 | 332,845 | 2.15 | Add 6.07% | 0.12 | $497.60 | $165,624,000 | SEC |
| 2024 Q4 | 313,784 | 2.26 | Reduce 25.90% | 0.88 | $520.23 | $163,240,000 | SEC |
| 2024 Q3 | 423,473 | 3.41 | Reduce 19.22% | 0.77 | $618.57 | $261,948,000 | SEC |
| 2024 Q2 | 524,248 | 3.98 | Add 13.92% | 0.49 | $553.00 | $289,909,000 | SEC |
| 2024 Q1 | 460,183 | 3.79 | Add 180.71% | 2.44 | $581.21 | $267,463,000 | SEC |
| 2023 Q4 | 163,937 | 1.24 | Reduce 51.56% | 1.44 | $530.79 | $87,016,000 | SEC |
| 2023 Q3 | 338,427 | 2.79 | Reduce 2.07% | 0.06 | $506.17 | $171,302,000 | SEC |
| 2023 Q2 | 345,573 | 2.73 | Reduce 43.74% | 2.36 | $521.75 | $180,303,000 | SEC |
| 2023 Q1 | 614,284 | 5.39 | Reduce 5.11% | 0.29 | $576.37 | $354,055,000 | SEC |
| 2022 Q4 | 647,343 | 5.76 | Reduce 29.94% | 2.31 | $550.69 | $356,485,000 | SEC |
| 2022 Q3 | 924,031 | 7.73 | Reduce 23.79% | 2.20 | $507.19 | $468,659,000 | SEC |
| 2022 Q2 | 1,212,500 | 9.23 | Add 0.49% | 0.05 | $543.28 | $658,727,000 | SEC |
| 2022 Q1 | 1,206,538 | 7.69 | Reduce 1.90% | 0.15 | $590.65 | $712,642,000 | SEC |
| 2021 Q4 | 1,229,899 | 7.99 | Add 7.65% | 0.57 | $667.24 | $820,638,000 | SEC |
| 2021 Q3 | 1,142,461 | 6.76 | Add 16.05% | 0.94 | $571.33 | $652,722,000 | SEC |
| 2021 Q2 | 984,437 | 5.60 | Add 33.78% | 1.41 | $504.47 | $496,619,000 | SEC |
| 2021 Q1 | 735,859 | 4.15 | Add 39.03% | 1.17 | $456.38 | $335,831,000 | SEC |
| 2020 Q4 | 529,274 | 3.18 | Add 21.57% | 0.56 | $465.78 | $246,525,000 | SEC |
| 2020 Q3 | 435,377 | 3.02 | Buy | 3.02 | $441.52 | $192,228,000 | SEC |